Wong for discussion and grading from the reaction intensity. == Microscopy and imaging. results can occur in interpreting the LPA1 antagonist 1 rabies IFA test. Staining patterns morphologically much like antirabies staining were observed in 7 of the 135 cerebrospinal fluid specimens examined. In addition, a majority of the cerebrospinal fluid specimens tested from patients with encephalitis offered immunoglobulin that bound to antigens present in the cell culture substrate. Of marked concern was the frequent presence of cross-reactive antibodies in encephalitis cases associated with West Nile and Powassan flaviviruses. Because IFA screening for rabies on human specimens may result in false-positive results, it should not be used as the sole basis for initiating antirabies treatment. == INTRODUCTION == Rapid accurate antemortem rabies diagnosis in humans has been imperative for palliative patient care and for treatment of individuals potentially exposed to the patient. The Milwaukee protocol (1) was launched as a potentially life-saving treatment for human rabies, and the sooner the protocol is initiated the greater the chances of success. This paradigm demands velocity and accuracy from your rabies diagnostician. The test most likely to supply a quick rabies diagnosis is the direct fluorescent-antibody (DFA) test (see Protocol for Postmortem Diagnosis of Rabies in Animals by Direct Fluorescent Antibody Screening [www.cdc.gov/rabies/pdf/RabiesDFASPv2.pdf]) performed on a nuchal skin biopsy specimen from the patient. However, since the results of this test may be unfavorable in earlier stages of the disease, other procedures are relied upon and are carried out concurrently with the DFA test. The indirect fluorescent-antibody (IFA) test performed with cerebrospinal fluid (CSF) and serum specimens from rabies-suspect patients can yield results within a few hours. To perform an IFA test, serial dilutions of serum or CSF LPA1 antagonist 1 samples are placed on fixed, rabies virus-infected, cultured cells. If LPA1 antagonist 1 the serum or CSF contains antibodies to rabies, then these antibodies attach to rabies antigens present in the infected cell substrate. A fluorescein isothiocyanate (FITC)-labeled secondary antibody specific for human immunoglobulins is applied, and the slides are LPA1 antagonist 1 then examined by fluorescence microscopy. An experienced microscopist can identify fluorescent staining patterns indicating the presence of an immune response to rabies computer virus. The IFA test is usually a quick and sensitive process. However, the specificity of the assay has not been studied in detail. This study analyzed the specificity of the rabies IFA test through the examination of specimens from rabies-negative patients who presented with encephalitis of known or unknown origin. The results indicate that this specificity of the rabies IFA test is not 100%, and thus this test should not be the sole basis for initiating rabies therapy. == MATERIALS AND METHODS == == Cell culture. == BHK-21 cells (C-13; ATCC CCL10) (American Type Culture Collection, Rockville, MD) were used at passages 70 to 95. Mouse neuroblastoma cells (2) were used at passages 700 to 750. Both cell lines were cultured and managed as previously reported (3). == Computer virus inoculum. == The ERA strain of rabies computer virus (4) was utilized as the rabies antigen source in the IFA test procedure. The computer virus inoculum Rabbit Polyclonal to ZNF691 used to infect cells was obtained from a commercially available veterinary vaccine vial (5). Prior to use in the preparation of the IFA antigen slides, the stock computer virus was passaged twice in BHK-21 cells using the medium previously reported (3). At the second passage of cell confluence, the flasks were placed at 80C immediately. Cells were thawed to a frozen slurry, agitated, and refrozen at 80C. Upon thawing, lysed cellular debris was removed by centrifugation at 1,000 g, and aliquots were prepared from your supernatant for storage at 80C. == Antigen slide preparation. == Stored computer virus inocula experienced previously been titrated to identify endpoint values and infectivity profiles in both neuroblastoma and BHK-21 cell cultures. Virus inocula were added to trypsinized cells at a multiplicity of contamination and cell count suitable to produce 40 to 50% cell contamination with 3 days of growth at 34C with a 5% CO2atmosphere in a moist chamber incubator. Cells were produced on multiwell Teflon-coated slides (Cel-Line/Thermo Fisher Scientific catalog.